China · Delayed Price · Currency is CNY Zhejiang Medicine Statistics
Total Valuation
SHA:600216 has a market cap or net worth of CNY 13.85 billion. The enterprise value is 11.69 billion.
| Market Cap | 13.85B |
| Enterprise Value | 11.69B |
Important Dates
The last earnings date was Saturday, April 11, 2026.
| Earnings Date | Apr 11, 2026 |
| Ex-Dividend Date | Jul 21, 2025 |
Share Statistics
SHA:600216 has 947.91 million shares outstanding. The number of shares has increased by 0.91% in one year.
| Current Share Class | 947.91M |
| Shares Outstanding | 947.91M |
| Shares Change (YoY) | +0.91% |
| Shares Change (QoQ) | +2.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.28% |
| Float | 572.35M |
Valuation Ratios
The trailing PE ratio is 18.70 and the forward PE ratio is 12.37.
| PE Ratio | 18.70 |
| Forward PE | 12.37 |
| PS Ratio | 1.57 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 11.47 |
| P/OCF Ratio | 8.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.04, with an EV/FCF ratio of 9.68.
| EV / Earnings | 15.56 |
| EV / Sales | 1.33 |
| EV / EBITDA | 8.04 |
| EV / EBIT | 15.68 |
| EV / FCF | 9.68 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.39 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 0.79 |
| Interest Coverage | 30.03 |
Financial Efficiency
Return on equity (ROE) is 5.60% and return on invested capital (ROIC) is 6.66%.
| Return on Equity (ROE) | 5.60% |
| Return on Assets (ROA) | 3.31% |
| Return on Invested Capital (ROIC) | 6.66% |
| Return on Capital Employed (ROCE) | 6.18% |
| Weighted Average Cost of Capital (WACC) | 7.10% |
| Revenue Per Employee | 1.52M |
| Profits Per Employee | 129,202 |
| Employee Count | 5,815 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 3.20 |
Taxes
In the past 12 months, SHA:600216 has paid 171.05 million in taxes.
| Income Tax | 171.05M |
| Effective Tax Rate | 21.26% |
Stock Price Statistics
The stock price has increased by +6.96% in the last 52 weeks. The beta is 0.58, so SHA:600216's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +6.96% |
| 50-Day Moving Average | 15.98 |
| 200-Day Moving Average | 15.04 |
| Relative Strength Index (RSI) | 38.30 |
| Average Volume (20 Days) | 27,161,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600216 had revenue of CNY 8.82 billion and earned 751.31 million in profits. Earnings per share was 0.78.
| Revenue | 8.82B |
| Gross Profit | 2.69B |
| Operating Income | 745.40M |
| Pretax Income | 804.40M |
| Net Income | 751.31M |
| EBITDA | 1.45B |
| EBIT | 745.40M |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 3.24 billion in cash and 957.35 million in debt, with a net cash position of 2.28 billion or 2.41 per share.
| Cash & Cash Equivalents | 3.24B |
| Total Debt | 957.35M |
| Net Cash | 2.28B |
| Net Cash Per Share | 2.41 |
| Equity (Book Value) | 11.37B |
| Book Value Per Share | 11.75 |
| Working Capital | 5.04B |
Cash Flow
In the last 12 months, operating cash flow was 1.68 billion and capital expenditures -473.62 million, giving a free cash flow of 1.21 billion.
| Operating Cash Flow | 1.68B |
| Capital Expenditures | -473.62M |
| Depreciation & Amortization | 706.83M |
| Net Borrowing | 160.31M |
| Free Cash Flow | 1.21B |
| FCF Per Share | 1.27 |
Margins
Gross margin is 30.46%, with operating and profit margins of 8.45% and 8.52%.
| Gross Margin | 30.46% |
| Operating Margin | 8.45% |
| Pretax Margin | 9.12% |
| Profit Margin | 8.52% |
| EBITDA Margin | 16.47% |
| EBIT Margin | 8.45% |
| FCF Margin | 13.69% |
Dividends & Yields
This stock pays an annual dividend of 0.28, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 0.28 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | 146.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 50.00% |
| Buyback Yield | -0.91% |
| Shareholder Yield | 1.01% |
| Earnings Yield | 5.42% |
| FCF Yield | 8.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.
| Last Split Date | Oct 9, 2013 |
| Split Type | Forward |
| Split Ratio | 1.8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |